Aspirin Use and Risk of Type 2 Diabetes in Apparently Healthy Men

2009/02/22 by Yasuaki Hayashino, Charles H. Hennekens, Tobias Kurth · 7 citations
Medicine · #Antiplatelet Therapy and Cardiovascular Diseases #Inflammatory mediators and NSAID effects #Diabetes, Cardiovascular Risks, and Lipoproteins

paper · doi:10.1016/j.amjmed.2008.09.044

Cited by

• Effect of aspirin on healthspan in community-dwelling older adults: the ASPirin in reducing events in the elderly study
• Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. [europepmc]
• Will Proton Pump Inhibitors Increase the Risk of Diabetes Mellitus? A Systemic Review and Meta-Analysis. [europepmc]
• A Hot Water Extract of Curcuma longa L. Improves Fasting Serum Glucose Levels in Participants with Low-Grade Inflammation: Reanalysis of Data from Two Randomized, Double-Blind, Placebo-Controlled Trials. [europepmc]
• Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial. [europepmc]
• Curcuma longa extract reduces serum inflammatory markers and postprandial hyperglycemia in healthy but borderline participants with overweight and glycemia in the normal/prediabetes range: a randomized, double-blind, and placebo-controlled trial. [europepmc]
• Daily low dose aspirin halves incident type 2 diabetes in elderly subjects with prediabetes: a five-year longitudinal cohort study in a real-word population. [europepmc]